galcanezumab
General
Pronunciation: 
gal-ka-nez-ue-mab
 To hear audio pronunciation of this topic, purchase a subscription or log in.
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Emgality
Ther. Class.
vascular headache suppressants
Pharm. Class.
monoclonal antibodies
calcitonin gene-related peptide receptor antagonists
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Galcanezumab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110685/10/galcanezumab. 
Vallerand AHA, Sanoski CAC,  . Galcanezumab. Davis's Drug Guide. F.A. Davis Company; 2025. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110685/10/galcanezumab. Accessed October 31, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). Galcanezumab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110685/10/galcanezumab
Vallerand AHA, Sanoski CAC,  . Galcanezumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 31]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110685/10/galcanezumab.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  galcanezumab
ID  -  110685
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110685/10/galcanezumab
PB  -  F.A. Davis Company
ET  -  19
DB  -  Pediatrics Central
DP  -  Unbound Medicine
ER  -  

 Davis's Drug Guide
Davis's Drug Guide

